Amicus Therapeutics Inc (NASDAQ:FOLD)

10.96
Delayed Data
As of Mar 27
 +0.29 / +2.72%
Today’s Change
1.77
Today|||52-Week Range
13.20
+31.73%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 15.00, with a high estimate of 19.00 and a low estimate of 15.00. The median estimate represents a +36.86% increase from the last price of 10.96.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$0.00
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.53%
 
 
 
 
 
 
Growthannually -19.89%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account